MedPath

Effect of nebulized Salbutamol versus Epinephrine in treatment of transient tachypnea of neonates

Phase 3
Recruiting
Conditions
Transient Tachypnea of Neonates.
Transient tachypnea of newborn
P22.1
Registration Number
IRCT20221028056324N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Transient tachypnea of neonates
Neonatal intensive care unit

Exclusion Criteria

First minute apgar below 4
Respiratory distress syndrome caused by surfactant deficiency
Congenital anomalies
Syndromes of chromosomal disorders
Congenital heart diseases
Premature neonatal sepsis
Meconium aspiration
Infants with metabolic disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Respiratory rate. Timepoint: Half an hour, one hour and four hours after nebulizer administration. Method of measurement: Physical examination.;Heart rate. Timepoint: Half an hour, one hour and four hours after nebulizer administration. Method of measurement: Noninvasive pulsoxymetry.;Oxygen saturation. Timepoint: Half an hour, one hour and four hours after nebulizer administration. Method of measurement: Noninvasive pulsoxymetry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath